Free Trial

Canopy Growth Target of Unusually High Options Trading (NASDAQ:CGC)

Canopy Growth logo with Medical background

Key Points

  • Canopy Growth experienced a significant surge in options trading, with 24,173 call options purchased, marking a 50% increase compared to typical trading volumes.
  • In insider trading news, Christelle Gedeon sold 16,929 shares at an average price of $1.74, resulting in a 4.39% decrease in their ownership stake.
  • Analysts have mixed ratings on Canopy Growth, with one upgrading the stock to "hold" while others maintain a "sell" rating, leading to an average rating of "sell" across reports.
  • Interested in Canopy Growth? Here are five stocks we like better.

Canopy Growth Corporation (NASDAQ:CGC - Get Free Report) was the recipient of unusually large options trading on Tuesday. Stock traders bought 24,173 call options on the stock. This is an increase of 50% compared to the typical volume of 16,155 call options.

Insider Activity at Canopy Growth

In related news, insider Christelle Gedeon sold 16,929 shares of the business's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $1.74, for a total transaction of $29,456.46. Following the transaction, the insider directly owned 368,488 shares in the company, valued at $641,169.12. The trade was a 4.39% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Over the last three months, insiders sold 27,225 shares of company stock valued at $47,915. Insiders own 0.16% of the company's stock.

Institutional Trading of Canopy Growth

Institutional investors have recently bought and sold shares of the business. Boothbay Fund Management LLC purchased a new stake in shares of Canopy Growth in the 2nd quarter valued at about $30,000. Dimensional Fund Advisors LP purchased a new stake in shares of Canopy Growth in the 4th quarter valued at about $41,000. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Canopy Growth by 81.3% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 32,336 shares of the company's stock valued at $41,000 after purchasing an additional 14,498 shares during the last quarter. Mackenzie Financial Corp lifted its holdings in shares of Canopy Growth by 56.5% in the 1st quarter. Mackenzie Financial Corp now owns 50,413 shares of the company's stock valued at $47,000 after purchasing an additional 18,202 shares during the last quarter. Finally, Osaic Holdings Inc. increased its position in Canopy Growth by 77.6% in the 2nd quarter. Osaic Holdings Inc. now owns 75,335 shares of the company's stock valued at $92,000 after acquiring an additional 32,927 shares during the period. 3.33% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CGC has been the topic of a number of recent research reports. Zacks Research upgraded Canopy Growth to a "hold" rating in a research note on Tuesday, August 12th. Piper Sandler restated an "underweight" rating on shares of Canopy Growth in a research note on Friday, May 30th. One investment analyst has rated the stock with a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of "Sell".

Get Our Latest Research Report on Canopy Growth

Canopy Growth Stock Up 3.2%

NASDAQ:CGC traded up $0.05 during midday trading on Tuesday, reaching $1.44. The company had a trading volume of 14,525,390 shares, compared to its average volume of 11,332,396. The firm has a market capitalization of $344.18 million, a price-to-earnings ratio of -0.47 and a beta of 0.77. The stock's fifty day simple moving average is $1.30 and its 200-day simple moving average is $1.28. Canopy Growth has a 12-month low of $0.77 and a 12-month high of $5.80. The company has a current ratio of 3.07, a quick ratio of 2.12 and a debt-to-equity ratio of 0.59.

Canopy Growth (NASDAQ:CGC - Get Free Report) last released its earnings results on Friday, August 8th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.15) by $0.01. The firm had revenue of $52.98 million during the quarter, compared to analyst estimates of $64.98 million. Canopy Growth had a negative return on equity of 89.93% and a negative net margin of 155.76%. On average, sell-side analysts anticipate that Canopy Growth will post -2.81 earnings per share for the current fiscal year.

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.